Global Cell Therapy Technologies Market to Grow with a CAGR of 13.6% During 2021-2030; Market to Grow on Account of Growing Incidences of Chronic Diseases Worldwide

Kenneth Research published a report titled Cell Therapy Technologies Market: Global Demand Analysis & Opportunity Outlook 2030 which delivers detailed overview of the global cell therapy technologies market in terms of market segmentation by product, process, cell type, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global cell therapy technologies market is anticipated to grow with a CAGR of 13.6% over the forecast period, i.e., 2021 – 2030. The market is segmented by product into consumables, system & software, and equipment, out of which, the consumables segment is anticipated to garner the largest revenue of USD 17892.6 Million by the end of 2030. Moreover, in the year 2020, the segment registered a revenue of USD 5163.6 Million.

The global cell therapy technologies market is estimated to garner a revenue of USD 45754.6 Million by the end of 2030, up from a revenue of USD 12902.1 Million in the year 2020. Increasing research and developments in the field of cell-based immunotherapies, such as CAR-T therapy, followed by the increasing need for newer, better therapies for diseases, such as cancer and cardiovascular diseases (CVDs) among others, are some of the major factors anticipated to drive the growth of the market in the coming years.

By region, the global cell therapy technologies market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Out of these, the market in North America region is anticipated to garner the largest revenue of USD 19957.2 Million by the end of 2030. Moreover, in the year 2020, the market in the region generated a revenue of USD 5848.5 Million.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Growing Concerns for the Increasing Prevalence of Chronic Diseases to Accelerate Market Growth

Out of 10 adults, 6 adults were known to have a chronic disease in the United States, as per the statistics by the United States Centers for Disease Control and Prevention (CDC).

The increasing prevalence of chronic diseases is one of the major factors that is driving the need for advanced treatment techniques around the globe. As a result, the healthcare organizations worldwide are increasingly investing on to research and develop advanced drugs or vaccines by the use of cell therapy technologies, which in turn, is anticipated to drive the growth of the global cell therapy technologies market.

However, the high cost of the vaccine or drug developed from cell therapy technologies is expected to operate as key restraint to the growth of global cell therapy technologies market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global cell therapy technologies market which includes company profiling of Lonza Group Ltd., Sartorius AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Avantor, Inc., Eppendorf SE, Miltenyi Biotec B.V. & Co. KG, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global cell therapy technologies market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Request Sample Report: https://www.kennethresearch.com/sample-request-10352227

Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: sales@kennethresearch.com

U.S. Phone: +1 313 462 0609


Related News